In Vitro Fertilization (IVF)

By: RMA of Philadelphia  11/11/2014
Keywords: Infertility Treatment, Artificial Insemination, Fertility Treatment

In Vitro Fertilization (IVF) is the process in which oocytes (eggs) are fertilized outside the body. There are several steps required for IVF. The first step is ovulation induction in which medication is taken in order to produce multiple follicles and eggs. The next step in the process is oocyte retrieval, where the matured oocytes are removed from the ovaries. In a process called insemination, the oocytes are exposed to sperm to fertilize the eggs in order to generate embryos. Embryos are then transferred back to the uterus. The time period after oocyte retrieval and embryo transfer is the luteal phase. Extra embryos are typically cryopreserved, according to each individual’s wishes.

Keywords: Artificial Insemination, Assisted Hatching, Assisted Reproductive Technology, Donor Egg, egg freezing, Egg Preservation, Embryo Freezing, Fertility Center, Fertility Clinic, Fertility Clinics, Fertility Doctor, Fertility Specialist, Fertility Testing, Fertility Treatment, Infertility Care, Infertility Clinic, Infertility Doctor, Infertility Specialist, Infertility Surgery, Infertility Treatment, Intracytoplasmic Sperm Injection, Intrauterine Insemination, Ivf Clinic, Ivf Doctor, Ivf Pregnancy, Ivf Program, Ivf Treatment, polycystic ovarian syndrome, Reproductive Endocrinology, Reproductive Technology

Other products and services from RMA of Philadelphia

02/15/2017

Fertility Testing

During a patient’s first visit, they will be evaluated to determine why pregnancy has not yet occurred. Each patient will


02/15/2017

Antral Follicle Count

An antral follicle count test uses a transvaginal ultrasound (internal) in order to measure a woman’s ovarian reserve (quantity of


02/15/2017

Semen Analysis

For this test, a semen sample is collected. The semen must be analyzed within a few hours after production to


02/15/2017

Anti-Mullerian Hormone Test (AMH)

An anti-Mullerian hormone (AMH) test is used to determine the quantity of a woman’s ovarian reserve. AMH is a protein


02/15/2017

Ovarian Reserve Testing

Ovarian reserve testing is the process of evaluating several hormone levels between days 2, 3, and 4 of a woman’s


02/15/2017

Gestational Surrogacy

A gestational carrier is a woman who carries a pregnancy for another couple or individual. This process begins when one


02/15/2017

Infertility Medications

Oral medications for infertility treatment such as, Clomiphene Citrate, and Letrozole. Injectable medications for infertility treatment such as follicle stimulating


02/15/2017

Intrauterine insemination (IUI)

Intrauterine insemination (IUI) is typically prescribed for patients with unexplained infertility, mild male factor infertility, or for women with cervical


10/08/2014

Donor Egg Program

Egg (oocyte) donation is an important option for many patients, and is recommended for women who have age-related infertility, poor egg quality, premature menopause, or diminished ovarian reserve. Also, women who have certain genetic diseases are also excellent candidates for donor eggs.


10/08/2014

Preimplantation Genetic Diagnosis

RMA of Philadelphia and Central Pennsylvania are pleased to offer preimplantation genetic diagnosis (PGD) testing, which screens an embryo for certain genetic disorders. A single cell from an embryo created through in vitro fertilization (IVF) can be tested for a number of common genetic abnormalities, such as Down’s syndrome, cystic fibrosis and muscular dystrophy. PGD may be considered for couples with a known history of severe inherited genetic disease, ensuring that only normal embryos are


10/08/2014

Single-Embryo Transfer (SET) with Comprehensive Chromosome Screening (CCS)

A new reproductive technology used with single-embryo transfer (SET) is helping fertility specialists achieve more pregnancies with fewer miscarriages. RMA of Philadelphia and Central Pennsylvania are offering SET with comprehensive chromosome screening (CCS), especially for patients ages 35 or older, or with multiple unsuccessful in vitro fertilization (IVF) cycles or miscarriages. The new test helps confirm that the embryo selected for transfer has the correct number of chromosomes and so is m